AIAENG:NSEAIA Engineering Limited Analysis
Data as of 2026-07-01 - not real-time
₹5,005.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
AIA Engineering has delivered record quarterly and full‑year profits, with FY revenue of INR 4,355 crore and PAT of INR 1,270 crore. Revenue growth of roughly 9 % and a gross margin of 55 % underline solid operating performance. The company generates robust cash, holding INR 43.8 billion in cash against modest debt of INR 0.1 billion, yielding a debt‑to‑equity of just 0.13. Return metrics are respectable, with ROE near 17 % and ROA around 9 %. However, the current market price of INR 5,005 is far above the DCF‑derived fair value of INR 977, implying a steep overvaluation. The price‑to‑earnings multiple sits at 36.8×, well above the industry average of 32.2×, and the price‑to‑book is 5.8×. The dividend payout is modest at 11.8 % of earnings, supporting a sustainable yield of 0.31 %. Technical indicators show strong bullish momentum: the 20‑day SMA (≈4,651) is well above the 50‑day SMA (≈4,287) and the 200‑day SMA (≈3,802). RSI is elevated at 72, suggesting the stock is in overbought territory. MACD remains bullish with a positive histogram of about 30 points.
Volume is increasing, and the 30‑day volatility is high at roughly 32 %, indicating sizable price swings. The fear‑greed index reads “Extreme Greed,” reflecting heightened market optimism that may be unwarranted given the valuation gap.
Volume is increasing, and the 30‑day volatility is high at roughly 32 %, indicating sizable price swings. The fear‑greed index reads “Extreme Greed,” reflecting heightened market optimism that may be unwarranted given the valuation gap.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought zone
- Proximity to 52‑week high
- Valuation gap vs DCF
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong earnings momentum
- Robust cash position
- Sustainable dividend
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Significant overvaluation
- High volatility
- Limited upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth9.40%
Profit Margin28.74%
P/E Ratio36.8
ROE16.95%
ROA8.73%
Debt/Equity0.13
P/B Ratio5.8
Op. Cash Flow₹5.9B
Free Cash Flow₹2.4B
Industry P/E32.2
Technical Analysis
TrendBullish
RSI72.3
Support₹4,290.50
Resistance₹5,180.00
MA 20₹4,650.79
MA 50₹4,287.14
MA 200₹3,802.24
MACDBullish
VolumeIncreasing
Fear & Greed Index90.96
Valuation
Fair Value₹976.79
Target Price₹4,492.54
Upside/Downside-10.24%
GradeOvervalued
TypeGrowth
Dividend Yield0.31%
Risk Assessment
Beta0.74
Volatility31.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.